D.Western Therapeutics InstituteD.Western Therapeutics Institute, Inc.4576東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP

D.Western Therapeutics Institute FY ending Dec 2019 results

D.Western Therapeutics Institute brought in ¥580.5M in revenue.

Out of every ¥100 of sales, about ¥20 is left as operating profit.

Where the money goes

For every ¥100 D.Western Therapeutics Institute sells, how much goes where, and how much is kept.

FY ending Dec 2019

Margin funnel (derived from reported values)Gross margin 95.5% → Operating margin 20.2% → Net margin 22.9%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第26期(2023/01/01－2023/12/31)
ID S100T4H92024-03-27Open
EDINET (FSA Japan)
有価証券報告書－第24期(令和3年1月1日－令和3年12月31日)
ID S100NR772022-03-29Open
EDINET (FSA Japan)
有価証券報告書－第23期(令和2年1月1日－令和2年12月31日)
ID S100KZGC2021-03-23Open

Extracted from XBRL: 37

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.